Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLEDepartment of Health and Human Services$5.0M obligationsEnds Sep 19, 2027
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES…Department of Health and Human Services$68.0M obligationsEnds Jul 28, 2027
THE PURPOSE OF THIS TASK ORDER IS TO (A) ACQUIRING, PROCURING AND/OR MANUFACTURING MATERIALS REQUIRED FOR THE GENERATION OF A SCALABLE IN VITRO TRANSCRIPTION (IVT) REACTION, THE…Department of Health and Human Services$6.8M obligationsEnds Mar 28, 2027
POPULATION HEALTH RESEARCH SUPPORT - TASK ORDER A: START UP, PREPARATION, AND TEST ENROLLMENT FOR THE TIMING OF DELIVERY (TIME) AIM OF THE STUDY OF PREGNANCY AND NEONATAL HEALTH…Department of Health and Human Services$432.6K obligationsEnds Aug 31, 2024
IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA)Department of Health and Human Services$24.0M obligationsEnds Jun 20, 2026
A STUDY IN MEDICARE ADVANTAGE FOR REAL WORLD EVIDENCE IN CARDIOVASCULAR DISEASEDepartment of Health and Human Services$1.6M obligationsEnds Jun 28, 2027
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020)Department of Health and Human Services$35.6M obligationsEnds Dec 31, 2030
IGF::OT::IGF NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$6.1M obligationsEnds Dec 14, 2024
"ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES"Department of Health and Human Services$18.2M obligationsEnds May 31, 2028
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$5.1M obligationsEnds Mar 29, 2027
VIROLOGY CORE LABORATORYDepartment of Health and Human Services$1.9M obligationsEnds Dec 14, 2026
FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNADepartment of Health and Human Services$5.9M obligationsEnds Aug 27, 2028
IGF::OT::IGF NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$18.0M obligationsEnds Mar 29, 2025
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)Department of Health and Human Services$12.1M obligationsEnds Sep 29, 2027
VIROLOGY QUALITY ASSURANCE (VQA)Department of Health and Human Services$3.4M obligationsEnds Jun 20, 2027
NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS…Department of Health and Human Services$4.8M obligationsEnds Jun 3, 2027
HHSN275201800008I - NEW TASK ORDER PHASE 2: RECRUITMENT AND FOLLOW-UP STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) (AIMS 1 AND 2) - DUKE UNIVERSITY - CAN 8050079Department of Health and Human Services$1.1M obligationsEnds May 31, 2027
IWR - BAYESIAN ENHANCEMENT OF FLOOD RISK MANAGEMENT DEPTH-DAMAGE MODELING. INCORPORATE A HIERARCHICAL BAYESIAN METHODOLOGY TO IMPROVE THE ACCURACY, INTERPRETABILITY, AND…Department of Defense$206.5K obligationsEnds Sep 29, 2026
PHARMACOKINETIC AND SAFETY OF ANTIRETROVIRAL AND RELATED DRUGS LACTATING WOMEN AND BREASTFED INFANTS STUDYDepartment of Health and Human Services$685.6K obligationsEnds Jun 30, 2026
RC20-3054 FY21 SERDP FUNDS, $100,000.00Department of Defense$1.9M obligationsEnds Jun 19, 2027
BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICSDepartment of Health and Human Services$8.8M obligationsEnds Sep 27, 2027
TASK ORDER 75N93022F00001 BASE AWARDDepartment of Health and Human Services$959.5K obligationsEnds Jan 13, 2027
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPINGDepartment of Health and Human Services$2.9M obligationsEnds Nov 30, 2026
THE GOAL OF THIS TASK ORDER IS TO PERFORM PHARMACOEPIDEMIOLOGY RESEARCH AND A PK, PHARMACODYNAMIC, PHARMACOGENOMIC, EFFICIENCY, AND SAFETY TRIAL OF THE HIGHEST RECOMMENDED DOSE…Department of Health and Human Services$1.5M obligationsEnds Feb 14, 2027
"DEFINING THE SAFETY AND EFFICACY OF POSTERIOR TIBIAL NERVE STIMULATION IN CHILDREN(POSITRON-C)"Department of Health and Human Services$862.1K obligationsEnds Sep 5, 2025